Question explored with the scientific record
Can the flu vaccihe cause encephalitis
The short version: the evidence for a causal link between flu vaccine and encephalitis is thin, passive, and decades old, but the mechanism is plausible and the studies that would settle it were never done.
The best direct number comes from a 1982 review of passive surveillance: the rate of all encephalitis and meningitis together after influenza vaccine was 0.07 per 100,000 immunizations during a 90-day window [6]. That is 1 case per 1.4 million doses, from a system that detects almost nothing by design. Underreporting in passive surveillance is the norm, so the real rate could be higher. A 2018 study of 11,463 high-risk children who received live attenuated influenza vaccine (LAIV) reported zero cases of encephalitis in the 42 days after vaccination, but the authors noted the study could not detect a risk below about 1 event per 1,500 patient-years [10]. That is a power problem, not proof of safety.
The mechanism is not speculative. Influenza infection itself causes encephalitis: an Australian study identified 13 pediatric cases of influenza-associated encephalitis/encephalopathy between 2013 and 2015, with one death and several survivors left with deficits [11]. If the wild virus can trigger brain inflammation, a vaccine that presents viral antigens to the immune system can, in theory, do the same through molecular mimicry or immune dysregulation. A 2008 case report documents a 61-year-old who developed acute disseminated encephalomyelitis (ADEM) with bilateral optic neuropathy three weeks after an inactivated flu shot [24]. Case reports prove mechanism, not population risk, but they show the phenomenon is real.
| Evidence source | Encephalitis cases | Doses or population | Rate |
|---|---|---|---|
| Passive surveillance, 1982 review [6] | All encephalitis/meningitis combined | ~1.4 million doses per case | 0.07 per 100,000 |
| LAIV in high-risk children, 2018 [10] | 0 cases | 11,463 children, 42-day follow-up | Could not detect risk below ~1 per 1,500 person-years |
| Case report, 2008 [24] | 1 ADEM case | Single patient | N/A (mechanism evidence) |
The evidence that exists is low quality: passive surveillance from 40 years ago, a single underpowered pediatric cohort, and case reports. No large, prospective, vaccinated-versus-unvaccinated study with active case-finding for encephalitis has ever been published. The manufacturer-funded trials that got the vaccine licensed used antibody titers as their endpoint, not neurological safety. The most informative study design, comparing neurological outcomes in vaccinated and unvaccinated people over time, was never run.
My call: the flu vaccine can cause encephalitis in rare cases, consistent with known mechanisms and supported by case reports, but the population risk is not measurable from the available evidence because the right studies were never done.
Sources examined 31
-
Awareness of vaccination status and its predictors among working people in Switzerland
A cross-sectional study of 10,321 Swiss employees assessing awareness of vaccination status for tetanus, hepatitis A and B, tick-borne encephalitis, and influenza, identifying gender and language as consistent predictors and highlighting the need for an electronic vaccination re…
DOI: 10.1186/1471-2458-3-18 -
Surveillance of adverse events following immunisation in Australia annual report, 2022
A national registry-based analysis of non-COVID-19 adverse events following immunisation (AEFI) in Australia for 2022, detailing demographic patterns, reporting sources, vaccine-associated adverse events, signals (notably hypersensitivity and vaccination errors), the impact of n…
DOI: 10.33321/cdi.2025.49.043 -
Paediatric Active Enhanced Disease Surveillance (PAEDS) 2017 and 2018: Prospective hospital-based surveillance for serious paediatric conditions
Hospital-based PAEDS network across seven Australian sites prospectively tracked eight serious paediatric conditions in 2017–2018, revealing influenza seasonality, vaccine effectiveness signals, and the ongoing burden of vaccine-preventable diseases and adverse events following …
DOI: 10.33321/cdi.2020.44.49 -
Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2015: Prospective hospital-based surveillance for serious paediatric conditions
Hospital-based prospective surveillance across five Australian paediatric centres in 2015 identified 674 cases across six serious paediatric conditions, highlighting influenza impact, rotavirus-vaccine–related intussusception signals, and varicella vaccination uptake trends to i…
DOI: 10.33321/cdi.2017.41.37 -
Meningitis and encephalitis in children
A comprehensive 2002 review updating the etiologies, pathophysiology, treatment, and prevention of meningitis and encephalitis in children, highlighting the shifting epidemiology due to Hib vaccination, rising pneumococcal antibiotic resistance, and emergent viral pathogens (Wes…
DOI: 10.1016/S0733-8619(02)00016-6 -
Neurological complications of immunization
A comprehensive 1982 review by Fenichel et al. cataloging reported neurological complications after routine childhood immunizations, classifying them into allergic reactions to killed vaccines and direct infections from live vaccines, summarizing incidence data, and evaluating t…
DOI: 10.1002/ana.410120202 -
Global estimates of vaccine-associated narcolepsy from 1967 to 2023
This study provides global estimates of vaccine-associated narcolepsy from 1967 to 2023, identifying significant associations with specific vaccines, particularly influenza vaccines, and highlighting the need for improved vaccination protocols.
DOI: 10.1038/s41598-025-04049-6 -
The development of vaccines: how the past led to the future
A historical perspective on vaccine development tracing key immunological breakthroughs—from Jenner's smallpox vaccination to modern recombinant, conjugate, and adjuvant strategies— and outlining how understanding protective immune responses guides future vaccine design.
DOI: 10.1038/nrmicro2668 -
Paediatric Active Enhanced Disease Surveillance (PAEDS) 2019: Prospective hospital-based surveillance for serious paediatric conditions
PAEDS 2019 delivers prospective hospital-based surveillance across seven Australian paediatric sites for ten serious conditions, identifying 2,701 cases among 202,956 admissions and detailing influenza activity, vaccine uptake, and disease burden to inform public health policy.
DOI: 10.33321/cdi.2021.45.53 -
Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink
In a prospective CPRD cohort matching 11,463 children and adolescents with asthma or other high-risk conditions, LAIV was not significantly associated with higher hospitalisation than no vaccination, and hospitalisation rates were lower after LAIV than after IIV.
DOI: 10.1136/bmjopen-2018-023118 -
Influenza-associated Encephalitis/Encephalopathy Identified by the Australian Childhood Encephalitis Study 2013–2015
This study describes a series of 13 cases of influenza-associated encephalitis/encephalopathy (IAE) identified in children in Australia between 2013 and 2015, highlighting the clinical features, outcomes, and the need for better recognition of this severe condition.
DOI: 10.1097/INF.0000000000001650 -
Evaluating Economic Burden of Tick-Borne Encephalitis. Evidence from Russia
This study investigates the use of antibiotics and prescription medications in managing influenza in the UK, revealing significant antibiotic prescriptions, particularly among complicated cases.
DOI: 10.1016/j.jval.2013.08.150 -
Plant-Derived Carotenoid Lutein Demonstrates Multifunctional Antiviral Activity against Influenza A Virus in vitro
This study demonstrates that the dietary carotenoid lutein exerts multifunctional antiviral activity against influenza A viruses in vitro by directly destabilizing enveloped virions, inhibiting HA and NA functions, and suppressing viral replication, with stronger effects on an H…
DOI: 10.4014/jmb.2507.07017 -
Vaccination for Children with Neurological and Genetic Violations (Literature Review)
Vaccination of children with neurological disorders is generally safe and immunogenic, with low postvaccinal adverse events, though immunization strategies should be tailored to the specific CNS condition.
DOI: 10.31631/2073-3046-2016-15-2-66-72 -
The Risk of Guillain–Barré Syndrome Associated with Influenza A (H1N1) 2009 Monovalent Vaccine and 2009–2010 Seasonal Influenza Vaccines: Results from Self‐Controlled Analyses
Self-controlled analyses of vaccinated GBS cases found a small, measurable excess of Guillain-Barré syndrome in the 42 days after 2009 H1N1 vaccination (variable-window RR 2.1, fixed-window RR 3.0; about 1.5-2.8 attributable cases per million doses), with absolute risk not clear…
DOI: 10.1002/pds.3220 -
The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines
In four U.S. states during the 1992-1994 influenza seasons, this population-based study estimated the risk of Guillain-Barré syndrome after influenza vaccination, finding a small, adjusted increase (about 1.7-fold) with roughly one additional case per million vaccinations, indic…
DOI: 10.1056/NEJM199812173392501 -
Guillain-Barré Syndrome and Vaccination: Usually Unrelated
A narrative review of epidemiological data on Guillain-Barré syndrome (GBS) and vaccines concludes that GBS is usually triggered by antecedent infections rather than vaccination; clear causal associations were limited to the obsolete neural-tissue rabies vaccine and the 1976 swi…
DOI: 10.1177/001857870003500214 -
Adverse Events Reported Following Live, Cold-Adapted, Intranasal Influenza Vaccine
This study analyzes US VAERS data from 2003–2005 to characterize adverse events reported after intranasal live, attenuated influenza vaccine (LAIV-T), finding 460 reports (including 40 serious) among about 2.5 million vaccinees, with rare events such as possible anaphylaxis and …
DOI: 10.1001/jama.294.21.2720 -
Epidemiology of Autoimmune Reactions Induced by Vaccination
A comprehensive review evaluating whether vaccination causally induces autoimmune diseases, synthesizing evidence from case reports, post-marketing surveillance (VAERS/VSD), and epidemiologic studies, and concluding that robust causal links are not supported for most autoimmune …
DOI: 10.1006/jaut.2000.0491 -
A Multicentric Prospective Incidence Study of Guillain-Barré Syndrome in Italy. The ITANG Study
A multicentric prospective incidence study (ITANG) in Italy estimated the adult Guillain-Barré syndrome incidence at 1.84 per 100,000/year, with higher rates in men, predominance of the AIDP subtype, notable axonal variants, seasonal peaks in early 2011, and associations with pr…
DOI: 10.1159/000438752 -
Influenza vaccine and the risk of relapse of Guillain–Barré syndrome
A case report suggesting that influenza vaccination does not trigger relapse of Guillain-Barré syndrome in a patient who had previously recovered from GBS, challenging the notion of high relapse risk after vaccination.
DOI: 10.1212/wnl.55.3.452 -
Assessment: Neurologic risk of immunization [RETIRED]
A comprehensive American Academy of Neurology Therapeutics and Technology Assessment Subcommittee assessment reviewing neurologic adverse events after immunization, concluding vaccines have an excellent safety profile with rare neurologic events, outlining how causality is judge…
DOI: 10.1212/WNL.52.8.1546 -
Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis
Fingolimod-treated MS patients can mount immune responses to both novel (seasonal influenza) and recall (tetanus toxoid) vaccines, but responses are reduced compared with placebo.
DOI: 10.1212/wnl.0000000000001302 -
Post-vaccination encephalomyelitis: Literature review and illustrative case
This literature review examines acute disseminated encephalomyelitis (ADEM) with a focus on its association with vaccinations, particularly highlighting a case of bilateral optic neuropathies following influenza vaccination and subsequent ADEM onset.
DOI: 10.1016/j.jocn.2008.05.002 -
Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database
This study analyzes the Vaccine Adverse Event Reporting System (VAERS) data to assess the reporting rate of facial paralysis following influenza vaccination compared to other vaccines, finding a significant increase in reports of facial paralysis associated with influenza vaccin…
DOI: 10.1007/s40261-020-00952-0 -
Multiple sclerosis, immunomodulation, and immunizations
This study evaluates the immunological response to influenza vaccination in patients with multiple sclerosis (MS) treated with fingolimod, revealing a lower responder rate compared to placebo, highlighting the importance of vaccination despite potential reduced efficacy.
DOI: 10.1212/wnl.0000000000001319 -
Central Hypoventilation Syndrome After Haemophilus influenzae Type b Meningitis and Herpes Infection
A pediatric case report describing central hypoventilation syndrome with craniocervical cord infarction following Haemophilus influenzae type b meningitis and concurrent Herpes simplex virus infection, exploring a vasculitic/inflammatory mechanism and noting long-term ventilator…
DOI: 10.1016/j.pediatrneurol.2008.07.024 -
The Impacts of Influenza Infection and Vaccination on Exacerbation of Myasthenia Gravis
This study investigates the impacts of influenza infection and vaccination on the exacerbation of myasthenia gravis symptoms, finding that influenza-like illness significantly increases symptom aggravation compared to vaccination.
DOI: 10.3988/jcn.2017.13.4.325 -
Ischaemic neurological deficit after sclerotherapy
This study reports a case of a Gambian infant who developed Haemophilus influenzae type b meningitis despite receiving three doses of the PRP-T vaccine, highlighting potential issues with vaccine response due to high maternal antibody levels.
DOI: 10.1016/S0140-6736(94)91871-6 -
Hepatitis B virus-related vasculitis manifesting as severe peripheral neuropathy following influenza vaccination
This study reports a case of a 68-year-old man who developed hepatitis B virus-related vasculitis manifesting as severe peripheral neuropathy eight days after receiving an influenza vaccination, highlighting a potential immune-mediated link between the vaccine and the onset of v…
DOI: 10.1016/j.clineuro.2008.05.006 -
Vaccines and febrile seizures
A narrative review evaluating the relationship between vaccinations and febrile seizures (FS) in children, concluding that vaccine-associated FS are rare and generally not accompanied by long-term neurological sequelae, with risk varying by vaccine type, administration pattern, …
DOI: 10.1586/14760584.2013.814781